Publikation & Awards

Combination of age, ABC-type and intratumoral_x000D_ T-regulator cells are a negative prognostic factors for_x000D_ primary extranodal diffuse large B-cell lymphoma

Tränkenschuh, W; Kemmerling, R; Alinger, B; Melchardt, T; Egle, A; Kiesslich, T; Neureiter, D PATHOLOGE . 2015; 36: 110-110.

Clinical results of triple negative breast cancer patients treated by IOERT-boost during breast conserving surgery

Fastner, G; Hauser-Kronberger, C; Moder, A; Reitsamer, R; Zehentmayr, F; Kopp, P; Greil, R; Fischer, T; Dietze, O; Sedlmayer, F; Radiotherapy and Oncology. 2015; 115(Supplement 1):235-235.-ESTRO 2015; 24.-28.04.2015; Barcelona.

Survival advantage of anastrozol compared to tamoxifen for lobular breast cancer in the ABCSG-8 study

Knauer, M; Gruber, C; Dietze, O; Greil, R; Stoger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Singer, C; Dubsky, P; Jakesz, R; Fitzal, F; Steger, G; Bartsch, R; Filipits, M; Fesl, C; Gnant, M CANCER RES. 2015; 75(9):

MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer

Gampenrieder, SP; Hamacher, F; Rinnerthaler, G; Hufnagl, C; Hackl, H; Romeder, F; Muss, C; Hauser-Kronbeger, C; Mlineritsch, B; Greil, R CANCER RES. 2015; 75(9):

Androgen receptor expression in pre-menopausal early breast cancer patients treated with endocrine therapy within the ABCSG-12 trial – a single center pilot analysis

Rinnerthaler, G; Knopp, AM; Hauser-Kronberger, C; Gampenrieder, SP; Morro, P; Mlineritsch, B; Fesl, C; Gnant, M; Greil, R CANCER RES. 2015; 75(9):

Immunotherapy of ovarian cancer

Weiss, L; Mlineritsch, B; Greil, R ONCOL RES TREAT. 2015; 38: 6-6.

Phase 3 trial of pembrolizumab as a first-line treatment in subjects with recurrent/metastatic head and neck squamous cell carcinoma: KEYNOTE-048

Klochikhin, A; Greil, R; Cohen, E; Vermorken, J; Harrington, K; Tahara, M; Ge, JY; Geib, J; Jin, F; Burtness, B ANN ONCOL. 2015; 26: 5-5.

Treatment in advanced ovarian cancer

Schonlieb, C ONCOL RES TREAT. 2015; 38: 205-205.

Tyrosin kinase inhibitors usage and response analysis in the Austrian CML registry cohort

Schmidt, S; Wolfler, A; Greil, R; Burgstaller, S; Sliwa, T; Petzer, A; Lang, A; Weltermann, A; Voskova, D; Mitterer, M; Valent, P; Eberhard, N; Walder, A; Geissler, K; Andel, J; Hausler, C; Ludescher, C; Oexle, H; Korger, M; Schnallinger, M; Schreieck, S; Krippl, P; Wiesholzer, M; Woll, E; Geissler, D; Rochau, U; Siebert, U; Thaler, J; Gastl, G ONCOL RES TREAT. 2015; 38: 133-133.

Integrin-linked kinase is induced by TNF alpha-NF-kappa B signals and required for centrosome clustering and mitotic spindle organization during chronic lymphocytic leukemia cell cycle progression

Krenn, P; Hofbauer, S; Pucher, S; Hutterer, E; Hinterseer, E; Asslaber, D; Sternberg, C; Neureiter, D; Aberger, F; Wickstroem, S; Greil, R; Hartmann, TN ONCOL RES TREAT. 2015; 38: 200-201.